Fenbendazole vs. Ivermectin for Cancer: Differences and Which Is Better?
Disclaimer: Fenbendazole is a veterinary medicine and is not FDA-approved for human use. This guide is for informational purposes only and does not constitute medical advice.
When standard treatments fall short, or stop working, many cancer patients find themselves asking:“What else is out there?”
That question often leads to a growing area of medical research known as drug repurposing, where existing, FDA-approved medications are studied for new uses, including cancer care.
Two of the most widely discussed drugs in this space are:
-
Ivermectin, an anti-parasitic used in humans
-
Fenbendazole, a veterinary dewormer
Although neither drug is FDA-approved for cancer treatment, early lab studies and real-world stories suggest they may affect cancer cells in promising ways; from slowing tumor growth to enhancing immune response.
Key Takeouts
- Fenbendazole and Ivermectin are anti-parasitic drugs being studied for potential anti-cancer properties, especially in cases resistant to standard treatments.
- Ivermectin has shown promise in laboratory studies for breast, ovarian, lung, melanoma, and colorectal cancers, where it may promote cancer cell death and improve the immune response.
- Fenbendazole has demonstrated activity against prostate, lung, and lymphoma cancers, potentially by disrupting cancer cell structure, inhibiting glucose use, and supporting tumor-suppressor genes.
- Early evidence suggests both drugs may enhance chemotherapy response and help overcome drug resistance, though neither is FDA-approved for cancer treatment.
- Patients exploring these repurposed drugs should do so under medical supervision, as safety, dosage, and potential interactions remain under study.
What Is Ivermectin?
Ivermectin is a drug that fights parasites and is used to treat different types of infections caused by parasites in humans. Additionally, it can be used to treat other health conditions such as river blindness and intestinal infections.
Ivermectin can also be used topically to treat conditions such as head lice and for skin conditions such as rosacea.
What Is Fenbendazole?
Fenbendazole is a benzimidazole that offers a wide-spectrum anthelmintic effect. It is a dewormer medication used to treat parasites in dogs and cats.
Some common names for Fenbendazole are Panacur® and Safe-Guard®.
How Ivermectin May Work Against Cancer
1.Targets Cancer Cells Without Harming Normal Cells
Clinical trials have shown that Ivermectin can effectively target cancer cells at dosages that are not harmful to normal cells.
2. Promotes Cancer Cell Death and Inhibits Growth
Research suggests that Ivermectin suppresses the growth and spread of cancer cells and promotes cancer cell death.
3. Enhances Chemotherapy and Overcomes Resistance
When used in combination with chemotherapy or other targeted drugs, it’s also been shown to have the ability to reverse tumor multidrug resistance.
Ivermectin has been found to be successful in fighting cancer cells. It has also demonstrated impressive effectiveness in treating cancer cells that are resistant to conventional chemotherapy drugs.
Shows Promise in Colorectal and Breast Cancers
Ivermectin has anti-tumor properties that have shown promise in treating colorectal cancer, which currently lacks an effective treatment. Its properties include being anti-viral, anti-inflammatory, and antitumor. In addition, a study has demonstrated that Ivermectin is effective in reducing the presence of multiple breast cancer cell lines.
How Fenbendazole May Work Against Cancer
1. Disrupts Cancer Cell Structure
Fenbendazole acts as a moderate destabilizing agent and possesses a potent antitumor effect. Fenbendazole causes cancer cells to erupt by modulating multiple cellular pathways.
2. Affects Metabolism and Tumor Suppression
To prove the effectiveness of using fenbendazole for cancer, a study treated human non-small cell lung cancer with this dewormer.
The cancer cells were analyzed, and researchers found that fenbendazole causes changes to the microtubule network on a cellular level. There was also an increase in the WT p53 tumor suppressor genes, which enhanced cell death-inducing activity.
3. Inhibits Glucose Use and Drug Resistance
Cancer cells have been shown to use more glucose to fuel their energy requirements. Researchers tested fenbendazole and found that it can inhibit glucose in the cell lines. It also has been found to be beneficial in evading the drug resistance encountered in cancer therapy.
Fenbendazole Vs. Ivermectin : Cancer-Specific Findings
Ivermectin and Cancer Types
Breast Cancer
Ivermectin has been found to turn cold breast tumors hot. Cold tumors mean there are little to no infiltrating T-cells. However, Ivermectin treatment led to robust T-cell infiltration, which turned the tumors into hot ones.
This suggests that Ivermectin could synergies with proteins like PD-1, to help bolster the immune system. This will increase immunity and help the body eradicate cancer.
Digestive System Cancer
Clinical studies show that dose-dependent Ivermectin inhibits the increase of glioblastoma cells in humans and induces apoptosis. Ivermectin has the potential to resist the development of tumor blood vessels and tumor metastasis.
Lung Cancer
Ivermectin significantly inhibits the production of lung cancer cells by inhibiting the YAP1 activity. Ivermectin can also reduce the metastasis of lung cancer cells by impeding EMT.
Melanoma
Melanoma cells were treated with Ivermectin and showed the potential to inhibit melanoma activity effectively.
Ovarian Cancer
Ivermectin has the potential to block a cell cycle and induce cell apoptosis in ovarian cancer. The combination of Ivermectin and Paclitaxel has a synergized effect on ovarian cancer. A combined treatment of these two almost completely inhibited tumor growth in vivo.
Urinary System Cancer
Ivermectin has been shown to significantly inhabit the growth of several forms of renal cancer cells while not affecting normal kidney cells. Ivermectin can also enhance the activity of other cancer drugs in the treatment of prostate cancer.
Colon Cancer
Ivermectin has been shown to have anti-virus, anti-inflammatory, and antitumor properties when it comes to colorectal cancer.
Fenbendazole and Cancer Types
Prostate cancer
Fenbendazole has been shown to be cytotoxic against paclitaxel-resistant prostate cancer.
Lung cancer
Fenbendazole has been found to be effective against small-cell lung cancer.
Joe Tippens had small-cell lung cancer that spread throughout his body and he was given only three months to live. He managed to cure his cancer with a mix of fenbendazole, curcumin, CBD oil, and vitamin E. He has been cancer-free ever since.
Lymphoma
A recent study shows that a combination of fenbendazole and supplemented vitamins inhibited the growth of human lymphoma cells in mice.
Overall, fenbendazole for humans has been shown to destroy the tubular structure of cancer cells. It can reduce the ability of cancer cells to metabolize and boost the body’s immune response to the cancer cells.
Fenbendazole can also induce the programmed cell death of cancer cells.
Fenbendazole Vs. Ivermectin - In Summary
Fenbendazole and Ivermectin are not approved for cancer treatment, but both are being studied for their potential roles in targeting cancer cells, especially in drug-resistant cases.
While early research and individual reports are promising, more clinical trials are needed before any conclusions can be drawn. If you’re considering integrative or repurposed options, it’s essential to do so under medical guidance.
